BRCATrue® Ashkenazi Jewish (3-site) is a site-specific genetic testing panel consisting of the three common BRCA1 and BRCA2 pathogenic variants found in the Ashkenazi Jewish population. These three mutations are defined as BRCA1 c.68_69delAG (also known as c.185delAG and c.187delAG), BRCA1 c.5266dupC (also known as c.5382insC), and BRCA2 c.5946delT (c.6174delT). Overall, these three pathogenic variants account for approximately 90-95% of all BRCA1 and BRCA2 pathogenic variants in individuals of Ashkenazi Jewish descent.
We have not reviewed this DNA test yet. If you have taken this test, please scroll down and click “Add your review.” All DNA tests that have not been reviewed receive a default score of 6/10 until reader reviews change the score.
BRCATrue® Ashkenazi Jewish (3-site) is a site-specific genetic testing panel consisting of the three common BRCA1 and BRCA2 pathogenic variants found in the Ashkenazi Jewish population. These three mutations are defined as BRCA1 c.68_69delAG (also known as c.185delAG and c.187delAG), BRCA1 c.5266dupC (also known as c.5382insC), and BRCA2 c.5946delT (c.6174delT). Overall, these three pathogenic variants account for approximately 90-95% of all BRCA1 and BRCA2 pathogenic variants in individuals of Ashkenazi Jewish descent.
BRCATrue® Ashkenazi Jewish (3-site) is a site-specific genetic testing panel consisting of the three common BRCA1 and BRCA2 pathogenic variants found in the Ashkenazi Jewish population. These three mutations are defined as BRCA1 c.68_69delAG (also known as c.185delAG and c.187delAG), BRCA1 c.5266dupC (also known as c.5382insC), and BRCA2 c.5946delT (c.6174delT). Overall, these three pathogenic variants account for approximately 90-95% of all BRCA1 and BRCA2 pathogenic variants in individuals of Ashkenazi Jewish descent.
